Focus: Poolbeg Pharma is a UK-based public pharmaceutical company focused on infectious disease drug development. The company operates with a lean pipeline and appears positioned as a development-stage player.
Profile data last refreshed 7h ago · AI intelligence enriched 3w ago
No open roles listed right now. Follow Poolbeg Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Poolbeg Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Poolbeg Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Roaring Waters raises Poolbeg Pharma stake to 6.55% - Proactive Investors
Roaring Waters raises Poolbeg Pharma stake to 6.55% Proactive Investors
Poolbeg Pharma secures Israeli patent approval for cancer immunotherapy drug POLB 001 - Pluang
Poolbeg Pharma secures Israeli patent approval for cancer immunotherapy drug POLB 001 Pluang
Poolbeg wins Israeli patent nod for lead cancer immunotherapy drug - Proactive Investors
Poolbeg wins Israeli patent nod for lead cancer immunotherapy drug Proactive Investors
Cavendish sees multi-billion-dollar prize as Poolbeg begins pivotal trial - Proactive Investors
Cavendish sees multi-billion-dollar prize as Poolbeg begins pivotal trial Proactive Investors
Discover UK Penny Stocks: Poolbeg Pharma And Two More Top Picks - simplywall.st
Discover UK Penny Stocks: Poolbeg Pharma And Two More Top Picks simplywall.st
Poolbeg Pharma secures South African patent for cancer immunotherapy drug POLB 001 until 2038 - Pluang
Poolbeg Pharma secures South African patent for cancer immunotherapy drug POLB 001 until 2038 Pluang
Showing 6 of 10 news items
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moRecent peer-reviewed publications with author affiliations at this company